AI Chat
Loading data for PMHS — first visit, this takes a few seconds.

Polomar Health Services, Inc.

PMHS · OTC Markets OTCQB · USD

0.20 +0.00 (0.00%)

At close: Sep 14, 2026, 8:00 PM

Market Cap
$5.68M

Polomar Health Services, Inc. (PMHS) Stock Price, Analysis & Data

Intrinsic Value

Loading intrinsic value…

Analyst Forecast

Stock Forecasts →

Analyst forecast unavailable

12-month target · n/a analysts

Analyst Consensus: n/a

Interval:1D
Loading candles and signals…

Financial Performance

View financials →

Loading...

Latest Earnings

ReportedVs estimateYoY Change
Revenuen/an/a
EPSn/an/a

Next Earnings

View earnings details →

Metrics

Bid
0.17
Net Income (ttm)
-9.55M
n/a
-0.35
n/a
n/a
P/B (ttm)
-5.41
P/S (ttm)
1.79
Earnings Date
n/a
Ask
0.3
Volume
5,000
Avg. Volume (20D)
3,192
Open
0.21
Previous Close
0.20
Day's Range
0.21 - 0.21
52-Week Range
0.07 - 0.80
Ex-Dividend Date
n/a
No News article available yet

About Polomar Health Services, Inc.

View profile →
Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California. Pharmaceutical Retailers · Healthcare

Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

Sector Healthcare
IPO Date Feb 9, 2009
Employees 6
Stock Exchange OTC Markets OTCQB
Ticker Symbol PMHS